Raaj Medisafe India Limited (BOM:524502)
India · Delayed Price · Currency is INR 85.01
-0.50 (-0.58%)
At close: Jan 22, 2026
Raaj Medisafe India Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 732.21 | 624.2 | 432.49 | 386.23 | 346.94 | 318.05 | Upgrade |
| 732.21 | 624.2 | 432.49 | 386.23 | 346.94 | 318.05 | Upgrade | |
Revenue Growth (YoY) | 62.86% | 44.33% | 11.98% | 11.32% | 9.08% | 45.92% | Upgrade |
Cost of Revenue | 502.23 | 442.96 | 295.26 | 270.56 | 266.87 | 252.75 | Upgrade |
Gross Profit | 229.99 | 181.25 | 137.23 | 115.67 | 80.07 | 65.3 | Upgrade |
Selling, General & Admin | 49.35 | 40.27 | 33.2 | 27.72 | 29.06 | 24.54 | Upgrade |
Other Operating Expenses | 73.73 | 54.66 | 37.67 | 31.83 | 0.1 | 0.04 | Upgrade |
Operating Expenses | 140.68 | 109.41 | 79.25 | 67.07 | 36.4 | 31.69 | Upgrade |
Operating Income | 89.31 | 71.84 | 57.98 | 48.6 | 43.67 | 33.61 | Upgrade |
Interest Expense | -25.85 | -20.18 | -14.56 | -10.59 | -6.62 | -7.31 | Upgrade |
Interest & Investment Income | 1.75 | 1.75 | 0.5 | 0.11 | 0.21 | 0.09 | Upgrade |
Currency Exchange Gain (Loss) | 0.01 | 0.01 | 0.01 | 0.06 | 0 | -0 | Upgrade |
Other Non Operating Income (Expenses) | 0.54 | -0.87 | -1.04 | -0.46 | -0.51 | -0.08 | Upgrade |
EBT Excluding Unusual Items | 65.76 | 52.55 | 42.89 | 37.72 | 36.75 | 26.31 | Upgrade |
Other Unusual Items | - | - | - | -0.01 | 0.53 | -0.12 | Upgrade |
Pretax Income | 65.76 | 52.55 | 42.89 | 37.72 | 37.27 | 26.19 | Upgrade |
Income Tax Expense | -11.17 | -8.76 | 9.6 | 4.42 | 7.15 | 3.19 | Upgrade |
Net Income | 76.93 | 61.31 | 33.29 | 33.3 | 30.13 | 22.99 | Upgrade |
Net Income to Common | 76.93 | 61.31 | 33.29 | 33.3 | 30.13 | 22.99 | Upgrade |
Net Income Growth | 135.66% | 84.20% | -0.04% | 10.52% | 31.03% | - | Upgrade |
Shares Outstanding (Basic) | 13 | 13 | 11 | 11 | 11 | 11 | Upgrade |
Shares Outstanding (Diluted) | 13 | 13 | 11 | 11 | 11 | 11 | Upgrade |
Shares Change (YoY) | 8.62% | 20.87% | - | 2.06% | -3.82% | 15.36% | Upgrade |
EPS (Basic) | 5.87 | 4.65 | 3.05 | 3.05 | 2.82 | 2.07 | Upgrade |
EPS (Diluted) | 5.82 | 4.60 | 3.05 | 3.05 | 2.82 | 2.07 | Upgrade |
EPS Growth | 115.00% | 50.69% | -0.04% | 8.29% | 36.23% | - | Upgrade |
Free Cash Flow | -176.41 | -147.96 | -73.64 | -15.52 | 12.35 | -16.6 | Upgrade |
Free Cash Flow Per Share | -13.46 | -11.23 | -6.75 | -1.42 | 1.16 | -1.50 | Upgrade |
Gross Margin | 31.41% | 29.04% | 31.73% | 29.95% | 23.08% | 20.53% | Upgrade |
Operating Margin | 12.20% | 11.51% | 13.41% | 12.58% | 12.59% | 10.57% | Upgrade |
Profit Margin | 10.51% | 9.82% | 7.70% | 8.62% | 8.68% | 7.23% | Upgrade |
Free Cash Flow Margin | -24.09% | -23.71% | -17.03% | -4.02% | 3.56% | -5.22% | Upgrade |
EBITDA | 106.91 | 86.32 | 66.35 | 56.12 | 50.91 | 40.72 | Upgrade |
EBITDA Margin | 14.60% | 13.83% | 15.34% | 14.53% | 14.67% | 12.80% | Upgrade |
D&A For EBITDA | 17.6 | 14.48 | 8.37 | 7.52 | 7.24 | 7.11 | Upgrade |
EBIT | 89.31 | 71.84 | 57.98 | 48.6 | 43.67 | 33.61 | Upgrade |
EBIT Margin | 12.20% | 11.51% | 13.41% | 12.58% | 12.59% | 10.57% | Upgrade |
Effective Tax Rate | - | - | 22.39% | 11.72% | 19.17% | 12.19% | Upgrade |
Revenue as Reported | 735.61 | 626.19 | 433.09 | 386.45 | 347.2 | 318.25 | Upgrade |
Advertising Expenses | - | 0.32 | 0.15 | 0.18 | 0.12 | 0.11 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.